• Je něco špatně v tomto záznamu ?

HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster

C. Matteo, G. Dovrtelova, A. Di Clemente, R. Frapolli, A. Passoni, T. Ceruti, G. Marsella, L. Cervo, M. Zucchetti,

. 2020 ; 1138 (-) : 121942. [pub] 20191218

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005583

A simple, sensitive HPLC-MS/MS method was developed and validated for the determination of lidocaine in skin and plasma of rats. The methods were established and validated assessing lower limit of quantitation (LLOQ), linearity, intra and inter-day precision and accuracy, selectivity, recovery and matrix effect. Chromatography was done on a Gemini column embedded with C18 stationary phase (50 mm × 2.0 mm, 5 µm particle size), using a gradient with mobile phases consisting of 0.1% HCOOH in bidistilled water and 0.1% HCOOH in acetonitrile. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring, using target ions m/z 235.10 for lidocaine and m/z 245.10 for lidocaine-d10, used as internal standard. RESULTS: The linearity of the method was in the ranges of lidocaine concentrations 10.0-200.0 ng/mL for skin homogenate (accuracy 94.1-105.5%; R2 ≥ 0.998) and 0.025-2 ng/mL for plasma (accuracy 96.2-104.8%; R2 ≥ 0.996). The intra- and inter-day precision and accuracy determined on three quality control samples (20, 75 and 170 ng/mL for skin and 0.075, 0.4 and 1.5 ng/mL for plasma) were ≤4.2% and 103.8-108.2% for skin and ≤12.4% and 95.5-101.4% for plasma. The LLOQ was 10 ng/mL in skin homogenate and 0.025 ng/mL in plasma. The applicability of the method was demonstrated by measuring lidocaine in skin and plasma after exposure to medicated patches containing 5% lidocaine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005583
003      
CZ-PrNML
005      
20200527082451.0
007      
ta
008      
200511s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jchromb.2019.121942 $2 doi
035    __
$a (PubMed)31918305
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Matteo, C $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
245    10
$a HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster / $c C. Matteo, G. Dovrtelova, A. Di Clemente, R. Frapolli, A. Passoni, T. Ceruti, G. Marsella, L. Cervo, M. Zucchetti,
520    9_
$a A simple, sensitive HPLC-MS/MS method was developed and validated for the determination of lidocaine in skin and plasma of rats. The methods were established and validated assessing lower limit of quantitation (LLOQ), linearity, intra and inter-day precision and accuracy, selectivity, recovery and matrix effect. Chromatography was done on a Gemini column embedded with C18 stationary phase (50 mm × 2.0 mm, 5 µm particle size), using a gradient with mobile phases consisting of 0.1% HCOOH in bidistilled water and 0.1% HCOOH in acetonitrile. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring, using target ions m/z 235.10 for lidocaine and m/z 245.10 for lidocaine-d10, used as internal standard. RESULTS: The linearity of the method was in the ranges of lidocaine concentrations 10.0-200.0 ng/mL for skin homogenate (accuracy 94.1-105.5%; R2 ≥ 0.998) and 0.025-2 ng/mL for plasma (accuracy 96.2-104.8%; R2 ≥ 0.996). The intra- and inter-day precision and accuracy determined on three quality control samples (20, 75 and 170 ng/mL for skin and 0.075, 0.4 and 1.5 ng/mL for plasma) were ≤4.2% and 103.8-108.2% for skin and ≤12.4% and 95.5-101.4% for plasma. The LLOQ was 10 ng/mL in skin homogenate and 0.025 ng/mL in plasma. The applicability of the method was demonstrated by measuring lidocaine in skin and plasma after exposure to medicated patches containing 5% lidocaine.
650    _2
$a zvířata $7 D000818
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a stabilita léku $7 D004355
650    _2
$a lidokain $x aplikace a dávkování $x analýza $x farmakokinetika $7 D008012
650    _2
$a limita detekce $7 D057230
650    _2
$a lineární modely $7 D016014
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a kůže $x chemie $7 D012867
650    _2
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
650    12
$a transdermální náplast $7 D057968
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dovrtelova, G $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Pharmacology, Faculty of Medicine, RECETOX Centre, Faculty of Science, Masaryk University and International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic.
700    1_
$a Di Clemente, A $u Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Frapolli, R $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Passoni, A $u Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Ceruti, T $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Marsella, G $u Animal Care Unit, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Cervo, L $u Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
700    1_
$a Zucchetti, M $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: massimo.zucchetti@marionegri.it.
773    0_
$w MED00006642 $t Journal of chromatography. B, Analytical technologies in the biomedical and life sciences $x 1873-376X $g Roč. 1138, č. - (2020), s. 121942
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31918305 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200527082448 $b ABA008
999    __
$a ok $b bmc $g 1524441 $s 1095639
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 1138 $c - $d 121942 $e 20191218 $i 1873-376X $m Journal of chromatography. B, Analytical technologies in the biomedical and life sciences $n J Chromatogr B Analyt Technol Biomed Life Sci $x MED00006642
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...